Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-07-03
1981-05-05
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
435 7, 435 34, G01N 3316, A61K 4300
Patent
active
042658730
ABSTRACT:
A cellular method for typing lymphocyte defined human leukocyte antigens by utilizing human blood leukocytes which have been sensitized to proliferatively respond to the secondary stimulus of the leukocyte antigens to which they have been sensitized. The sensitization is accomplished by incubating, in vitro, in a mixed leukocyte culture, the leukocytes to be sensitized with leukocytes differing by only a single major histocompatibility complex haplotype or a single HLA-D antigenic determinant.
REFERENCES:
patent: 3900461 (1975-08-01), Wilson et al.
Bach, Radioisotopes in Medicine: In Vitro Studies, U.S. Atomic Energy Commission, Jun. 1968, pp. 579-588.
Hirschberg et al., Chemical Abstracts, vol. 80, No. 21, May 27, 1974, p. 297, abstract No. 119104d.
Sheehy et al., Science, vol. 188, No. 4195, Jun. 27, 1975, pp. 1308-1310.
Bach Fritz H.
Bach Marilyn L.
Sheehy Michael J.
Sondel Paul M.
Wank Rudolf
Bremer Howard W.
Nucker Christine M.
Padgett Benjamin R.
Wisconsin Alumni Research Foundation
LandOfFree
Method for typing human leukocyte antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for typing human leukocyte antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for typing human leukocyte antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-295988